We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-2.59%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.32B
AUM Growth
-$184M
Cap. Flow
-$103M
Cap. Flow %
-4.44%
Top 10 Hldgs %
48.71%
Holding
92
New
20
Increased
22
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$139M
2
COR icon
Cencora
COR
+$76M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$69.6M
4
CNC icon
Centene
CNC
+$65.7M
5
MCK icon
McKesson
MCK
+$56.3M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$106M
2
HUM icon
Humana
HUM
+$106M
3
DHR icon
Danaher
DHR
+$103M
4
TMO icon
Thermo Fisher Scientific
TMO
+$92.3M
5
CVS icon
CVS Health
CVS
+$91.6M

Sector Composition

Rank Sector Weight
1 Healthcare 88.69%
2 Consumer Discretionary 4.5%
3 Real Estate 3.92%
4 Financials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
76
Danaher
DHR
$144B
– –
-434,190
Closed -$103M
DXCM icon
77
DexCom
DXCM
$32B
– –
-203,560
Closed -$21.7M
ELEV
78
DELISTED
Elevation Oncology
ELEV
– –
-100,000
Closed -$1.36M
LKFT
79
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
– –
-41,080
Closed -$2.83M
GLUE icon
80
Monte Rosa Therapeutics
GLUE
$1.35B
– –
-100,000
Closed -$2.27M
HUM icon
81
Humana
HUM
$46.2B
– –
-239,030
Closed -$106M
IRWD icon
82
Ironwood Pharmaceuticals
IRWD
$714M
– –
-522,712
Closed -$6.73M
MREO
83
Mereo BioPharma
MREO
$47.3M
– –
-149,170
Closed -$473K
NVAX icon
84
PUT
Novavax
NVAX
$1.31B
– –
-23,500
Closed -$4.99M
REGN icon
85
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-190,380
Closed -$106M
TMO icon
86
Thermo Fisher Scientific
TMO
$220B
– –
-182,970
Closed -$92.3M
VEEV icon
87
Veeva Systems
VEEV
$37.4B
– –
-136,080
Closed -$42.3M
VRTX icon
88
CALL
Vertex Pharmaceuticals
VRTX
$126B
– –
-187,000
Closed -$37.7M
ARYD
89
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-1,238,881
Closed -$13.3M
CYT
90
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
– –
-120,000
Closed -$2.57M
EQRX
91
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-500,000
Closed -$5.16M
JNCE
92
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-268,295
Closed -$1.82M
1 2 3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2021 Portfolio in Review

As of Q3 2021, HealthCor Management held 92 positions worth $2.32B, down 7.4% from $2.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HealthCor Management withdrew a net $103M in Q3 2021, closing 19 positions and reducing 16 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Consumer Discretionary and Real Estate.

Against the trend, HealthCor Management opened a new position in Jazz Pharmaceuticals worth $60M.

  • HealthCor Management's largest Q3 2021 buy was Jazz Pharmaceuticals: 460,790 shares worth $60M.
  • HealthCor Management added most to Bristol-Myers Squibb in Q3 2021, an estimated $139M increase.
  • HealthCor Management's biggest Q3 2021 reduction was CVS Health, cutting an estimated $91.6M.
  • HealthCor Management fully exited Regeneron Pharmaceuticals in Q3 2021, selling an estimated $106M.
  • HealthCor Management's ten largest holdings make up 49% of its $2.32B portfolio in Q3 2021.
  • HealthCor Management opened 20 new positions and closed 19 in Q3 2021.
  • HealthCor Management's portfolio value fell 7.4% quarter-over-quarter to $2.32B.

Based on HealthCor Management's 13F filing for Q3 2021, filed 15 Nov 2021.